It was later approved by the US FDA on October 28 , 2015 for stage 3 patients as adjuvant therapy .
Ipilimumab was approved by US FDA in March 2011 to treat patients with late - stage melanoma that has spread or can not be removed by surgery .
Ipilimumab was later approved by the US FDA on October 28 , 2015 for stage 3 patients as adjuvant therapy .
Ipilimumab was approved by US FDA in March 2011 to treat patients with late - stage melanoma that has spread or can not be removed by surgery .